D-Wave, Quantum

D-Wave Quantum: Record Backlog, a Scientific Squall, and a Washington-Backed Ambition

Published on 05/28/2026 at 15:02 | Redaktion boerse-global.de

D-Wave navigates quantum benchmark dispute, record Q1 bookings, $100M CHIPS Act support, and insider share sale amid 54% 30-day stock surge.

D-Wave Quantum: Record Backlog, a Scientific Squall, and a Washington-Backed Ambition Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de
D-Wave Quantum: Record Backlog, a Scientific Squall, and a Washington-Backed Ambition Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

D-Wave Quantum is catching crosswinds this week. A scientific challenge to its core quantum claims landed just as the company prepared to pitch investors at the TD Cowen Sustainability & Industrial Innovation Conference. Then came a fresh wave of federal backing, record bookings, and an insider share sale that left the stock zigzagging — volatility that its 133% annualised volatility statistic neatly captures for a name that has climbed 54% in the last 30 days.

Scientific credibility under fire

Two days before its conference appearance, D-Wave was forced to defend its performance benchmarks after the Flatiron Institute published a study arguing that classical simulation algorithms could match the output of its quantum processors. D-Wave’s technical leadership pushed back hard, pointing out that the algorithms tested had failed on the most complex three-dimensional spin-glass problems on cubic and diamond lattices. The company insists its “beyond-classical” benchmarks remain valid — a rebuttal that helped stabilise the stock after a mid-week dip. The shares recently changed hands at roughly €23, still about 40% below the 52-week high of €38.48, but more than double the year low set in late March.

A split-screen quarter

The first quarter of 2026 delivered a stark contradiction. Bookings hit a record $33.4 million — a near-2,000% surge from a year earlier — and remaining performance obligations jumped 563% to $42.4 million. Yet reported revenue collapsed to just $2.86 million, 81% below the prior-year period and well short of the $4.14 million consensus estimate. The drop was largely due to a one-off system sale in the year-ago quarter that distorted the comparison. On the bottom line, the loss per share of $0.05 beat the expected $0.08 loss. The company holds roughly $588 million in cash and securities, and its market capitalisation sits around $10 billion — a price-to-sales multiple near 791 that rests almost entirely on hope that those bookings convert into hard revenue.

Should investors sell immediately? Or is it worth buying D-Wave Quantum?

Washington deepens its bet

The U.S. Department of Commerce has delivered a non-binding letter of intent for $100 million under the CHIPS and Science Act, intended to accelerate D-Wave’s annealing and gate-model system development. In an unusual structure, the government would receive equity in exchange for the grant, effectively becoming a shareholder — a clear signal of D-Wave’s strategic importance to Washington. Part of the funding would support a new research and development centre in Boca Raton, Florida, adding to existing sites in New Haven and Burnaby. Separately, D-Wave has secured the second-year tranche of its SQFab project, part of a $25 million package through the NORDTECH consortium and the U.S. Microelectronics Commons program.

Insider selling meets institutional buying

A day after the Commerce announcement, chief financial officer John M. Markovich sold roughly 329,000 shares at an average of $27.70 each, netting about $9.1 million. The sale followed the exercise of stock options and cut his direct holdings by nearly 19%, leaving him with about 1.44 million shares. That move sits against a broader pattern: industry-wide, insiders at D-Wave, IonQ, and Rigetti have sold a net $931 million in shares over five years, with D-Wave alone accounting for $295 million in sales versus just $309,000 in insider purchases over the same period.

Institutional investors have taken the opposite view. Vanguard boosted its stake by 41% to 38.45 million shares, while UBS raised its position by more than 540% to 12.09 million shares. Funds and institutions now collectively own roughly 42% of the company.

The next proving ground: London

With the stock’s valuation so dependent on future revenue conversion, the critical test comes on June 18 in London at the Qubits Europe 2026 conference. D-Wave plans to showcase real-world applications of its dual-platform technology in logistics, artificial intelligence, and materials science. For a share price that trades almost entirely on expectations, tangible customer use cases may ultimately tell a more convincing story than any quarterly filing.

Ad

D-Wave Quantum Stock: New Analysis - 28 May

Fresh D-Wave Quantum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated D-Wave Quantum analysis...

Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.

en | US26740W1099 | D-WAVE | boerse | 69433163 |